{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:57:17Z","timestamp":1791334637820,"version":"4.3.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K16642"],"award-info":[{"award-number":["23K16642"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALS Foundation, Japan ALS Association","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84944-6","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:12:53Z","timestamp":1736226773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A single-center, single-arm, prospective, open-label, and comparative trial to evaluate the safety and tolerability profile of a 90-day oral L-arginine hydrochloride intervention for patients with amyotrophic lateral sclerosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Hiroyuki","family":"Naito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Toko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Tazuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keito","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Tachiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"84944_CR1","doi-asserted-by":"publisher","first-page":"11159","DOI":"10.1073\/pnas.0402026101","volume":"101","author":"L Dupuis","year":"2004","unstructured":"Dupuis, L. et al. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. U S A. 101, 11159\u201311164. https:\/\/doi.org\/10.1073\/pnas.0402026101 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"84944_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1242\/dmm.024786","volume":"9","author":"KS Coughlan","year":"2016","unstructured":"Coughlan, K. S., Halang, L., Woods, I. & Prehn, J. H. A high-fat jelly diet restores bioenergetic balance and extends lifespan in the presence of motor dysfunction and lumbar spinal cord motor neuron loss in TDP-43A315T mutant C57BL6\/J mice. Dis. Model. Mech. 9, 1029\u20131037. https:\/\/doi.org\/10.1242\/dmm.024786 (2016).","journal-title":"Dis. Model. Mech."},{"key":"84944_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.25661","volume":"87","author":"AC Ludolph","year":"2020","unstructured":"Ludolph, A. C. et al. Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann. Neurol. 87, 206\u2013216. https:\/\/doi.org\/10.1002\/ana.25661 (2020).","journal-title":"Ann. Neurol."},{"key":"84944_CR4","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s00726-014-1815-y","volume":"46","author":"DJ Ham","year":"2014","unstructured":"Ham, D. J., Caldow, M. K., Lynch, G. S. & Koopman, R. Arginine protects muscle cells from wasting in vitro in an mTORC1-dependent and NO-independent manner. Amino Acids. 46, 2643\u20132652. https:\/\/doi.org\/10.1007\/s00726-014-1815-y (2014).","journal-title":"Amino Acids"},{"key":"84944_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00726-002-0352-2","volume":"25","author":"J I\u0142zecka","year":"2003","unstructured":"I\u0142zecka, J. et al. Plasma amino acids concentration in amyotrophic lateral sclerosis patients. Amino Acids. 25, 69\u201373. https:\/\/doi.org\/10.1007\/s00726-002-0352-2 (2003).","journal-title":"Amino Acids"},{"key":"84944_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bbrc.2009.05.015","volume":"384","author":"J Lee","year":"2009","unstructured":"Lee, J., Ryu, H. & Kowall, N. W. Motor neuronal protection by L-arginine prolongs survival of mutant SOD1 (G93A) ALS mice. Biochem. Biophys. Res. Commun. 384, 524\u2013529. https:\/\/doi.org\/10.1016\/j.bbrc.2009.05.015 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"84944_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bbrc.2009.07.007","volume":"387","author":"J Lee","year":"2009","unstructured":"Lee, J., Ryu, H. & Kowall, N. W. Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice. Biochem. Biophys. Res. Commun. 387, 202\u2013206. https:\/\/doi.org\/10.1016\/j.bbrc.2009.07.007 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"84944_CR8","first-page":"585","volume":"25","author":"I Matsuda","year":"1997","unstructured":"Matsuda, I. et al. Clinical evaluation of arginine preparations (ARG-U granule and ARG-U injection) against hyperammonemia due to congenital urea cycle enzyme abnormality (excluding arginase abnormality) and congenital amino acid transfer abnormality in 17 centers nationwide. Japanese Pharmacol. Ther. 25, 585\u2013598 (1997). (in Japanese).","journal-title":"Japanese Pharmacol. Ther."},{"key":"84944_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1172-7-32","volume":"7","author":"J H\u00e4berle","year":"2012","unstructured":"H\u00e4berle, J. et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J. Rare Dis. 7, 32. https:\/\/doi.org\/10.1186\/1750-1172-7-32 (2012).","journal-title":"Orphanet J. Rare Dis."},{"key":"84944_CR10","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00726-018-2594-7","volume":"50","author":"C McNeal","year":"2018","unstructured":"McNeal, C. Safety of dietary supplementation with arginine in adult humans. Amino Acids. 50, 1215\u20131229. https:\/\/doi.org\/10.1007\/s00726-018-2594-7 (2018).","journal-title":"Amino Acids"},{"key":"84944_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/17482968.2012.678366","volume":"13","author":"T Shimizu","year":"2012","unstructured":"Shimizu, T. et al. Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: A multicenter study in Japan. Amyotroph. Lateral Scler. 13, 363\u2013366. https:\/\/doi.org\/10.3109\/17482968.2012.678366 (2012).","journal-title":"Amyotroph. Lateral Scler."},{"key":"84944_CR12","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s00415-019-09276-2","volume":"266","author":"T Shimizu","year":"2019","unstructured":"Shimizu, T. et al. Prognostic significance of body weight variation after diagnosis in ALS: A single-centre prospective cohort study. J. Neurol. 266, 1412\u20131420. https:\/\/doi.org\/10.1007\/s00415-019-09276-2 (2019).","journal-title":"J. Neurol."},{"key":"84944_CR13","doi-asserted-by":"publisher","first-page":"12262","DOI":"10.1038\/s41598-019-48831-9","volume":"9","author":"Y Nakayama","year":"2019","unstructured":"Nakayama, Y. et al. Body weight variation predicts disease progression after invasive ventilation in amyotrophic lateral sclerosis. Sci. Rep. 9, 12262. https:\/\/doi.org\/10.1038\/s41598-019-48831-9 (2019).","journal-title":"Sci. Rep."},{"key":"84944_CR14","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00415-009-5100-z","volume":"256","author":"C Bouteloup","year":"2009","unstructured":"Bouteloup, C. et al. Hypermetabolism in ALS patients: An early and persistent phenomenon. J. Neurol. 256, 1236\u20131242. https:\/\/doi.org\/10.1007\/s00415-009-5100-z (2009).","journal-title":"J. Neurol."},{"key":"84944_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/21678421.2019.1621346","volume":"20","author":"ST Ngo","year":"2019","unstructured":"Ngo, S. T. et al. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 20, 497\u2013505 https:\/\/doi.org\/10.1080\/21678421.2019.1621346 (2019).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"84944_CR16","doi-asserted-by":"publisher","unstructured":"Latif, S. & Kang, Y. S. Differences of transport activity of arginine and regulation on neuronal nitric oxide synthase and oxidative stress in amyotrophic lateral sclerosis model cell lines. Cell 10, 3554 (2021). https:\/\/doi.org\/10.3390\/cells10123554","DOI":"10.3390\/cells10123554"},{"key":"84944_CR17","doi-asserted-by":"publisher","first-page":"e23647","DOI":"10.1096\/fj.202400045R","volume":"38","author":"JPH Wong","year":"2024","unstructured":"Wong, J. P. H. et al. Characterization of the skeletal muscle arginine methylome in health and disease reveals remodeling in amyotrophic lateral sclerosis. FASEB J. 38, e23647. https:\/\/doi.org\/10.1096\/fj.202400045R (2024).","journal-title":"FASEB J."},{"key":"84944_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/hmg\/ddr448","volume":"21","author":"ML Tradewell","year":"2012","unstructured":"Tradewell, M. L. et al. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS\/TLS harbouring ALS-linked mutations. Hum. Mol. Genet. 21, 136\u2013149. https:\/\/doi.org\/10.1093\/hmg\/ddr448 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"84944_CR19","doi-asserted-by":"publisher","first-page":"e61576","DOI":"10.1371\/journal.pone.0061576","volume":"8","author":"C Scaramuzzino","year":"2013","unstructured":"Scaramuzzino, C. et al. Protein arginine methyltransferase 1 and 8 interact with FUS to modify its sub-cellular distribution and toxicity in vitro and in vivo. PLoS One. 8, e61576. https:\/\/doi.org\/10.1371\/journal.pone.0061576 (2013).","journal-title":"PLoS One"},{"key":"84944_CR20","doi-asserted-by":"publisher","first-page":"e1868","DOI":"10.1212\/WNL.0000000000007311","volume":"92","author":"K Ikenaka","year":"2019","unstructured":"Ikenaka, K. et al. Increase of arginine dimethylation correlates with the progression and prognosis of ALS. Neurology 92, e1868\u2013e1877. https:\/\/doi.org\/10.1212\/WNL.0000000000007311 (2019).","journal-title":"Neurology"},{"key":"84944_CR21","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/ene.15254","volume":"29","author":"K Ikenaka","year":"2022","unstructured":"Ikenaka, K. et al. Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis. Eur. J. Neurol. 29, 1410\u20131416. https:\/\/doi.org\/10.1111\/ene.15254 (2022).","journal-title":"Eur. J. Neurol."},{"key":"84944_CR22","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/brain\/awaa115","volume":"143","author":"EN Minakawa","year":"2020","unstructured":"Minakawa, E. N. et al. Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation. Brain 143, 1811\u20131825. https:\/\/doi.org\/10.1093\/brain\/awaa115 (2020).","journal-title":"Brain"},{"key":"84944_CR23","doi-asserted-by":"publisher","first-page":"19346","DOI":"10.1039\/d2cp02171d","volume":"24","author":"S Li","year":"2022","unstructured":"Li, S. et al. Mechanism underlying liquid-to-solid phase transition in fused in sarcoma liquid droplets. Phys. Chem. Chem. Phys. 24, 19346\u201319353. https:\/\/doi.org\/10.1039\/d2cp02171d (2022).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"84944_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/ncn3.12289","volume":"7","author":"Y Nishiyama","year":"2019","unstructured":"Nishiyama, Y., Abe, K., Tokunaga, J. & Numayama, T. Metabolic syndrome in advanced amyotrophic lateral sclerosis patients with tracheostomy\u2013invasive ventilation. Neurol. Clin. Neurosci. 7, 174\u2013179. https:\/\/doi.org\/10.1111\/ncn3.12289 (2019).","journal-title":"Neurol. Clin. Neurosci."},{"key":"84944_CR25","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner, J. M. et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 131, 1975\u20131978. https:\/\/doi.org\/10.1016\/j.clinph.2020.04.005 (2020).","journal-title":"Clin. Neurophysiol."},{"key":"84944_CR26","first-page":"456","volume":"10","author":"B Vellas","year":"2006","unstructured":"Vellas, B. et al. Overview of the MNA\u2013Its history and challenges. J. Nutr. Health Aging. 10, 456\u2013463 (2006).","journal-title":"J. Nutr. Health Aging"},{"key":"84944_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/s0022-510x(99)00210-5","volume":"169","author":"J Cedarbaum","year":"1999","unstructured":"Cedarbaum, J. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J. Neurol. Sci. 169, 13\u201321. https:\/\/doi.org\/10.1016\/s0022-510x(99)00210-5 (1999).","journal-title":"J. Neurol. Sci."},{"key":"84944_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/21678421.2016.1245756","volume":"18","author":"T Shimizu","year":"2017","unstructured":"Shimizu, T. et al. The measurement and estimation of total energy expenditure in Japanese patients with ALS: A doubly labelled water method study. Amyotroph. Lateral Scler. Frontotemporal Degener. 18, 37\u201345. https:\/\/doi.org\/10.1080\/21678421.2016.1245756 (2017).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"84944_CR29","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/bmc.1346","volume":"24","author":"K Shimbo","year":"2010","unstructured":"Shimbo, K. et al. Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography\/mass spectrometry. Biomed. Chromatogr. 24, 683\u2013691. https:\/\/doi.org\/10.1002\/bmc.1346 (2010).","journal-title":"Biomed. Chromatogr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84944-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84944-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84944-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T17:06:49Z","timestamp":1736269609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84944-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84944"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84944-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4788914\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1120"}}